Loading…

Cancer care in transgender and gender-diverse persons: results from two national surveys among providers and health service users by the Italian Association of Medical Oncology

Transgender and gender-diverse (TGD) population represents an underserved group across the cancer care continuum. To assess the perspective of both oncology health care providers (OHPs) and TGD individuals in Italy, we conducted two national surveys: one among 2407 OHPs about their attitudes, knowle...

Full description

Saved in:
Bibliographic Details
Published in:ESMO open 2023-06, Vol.8 (3), p.101578-101578, Article 101578
Main Authors: Leone, A.G., Miceli, R., Trapani, D., Massagrande, M., Morano, F., Marsoni, S., La Verde, N., Berardi, R., Casolino, R., Lambertini, M., Dalu, D., Di Maio, M., Beretta, G.D., Perrone, F., Cinieri, S., Pietrantonio, F.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Transgender and gender-diverse (TGD) population represents an underserved group across the cancer care continuum. To assess the perspective of both oncology health care providers (OHPs) and TGD individuals in Italy, we conducted two national surveys: one among 2407 OHPs about their attitudes, knowledge and behavior toward TGD patients, and one among TGD persons about their health needs, experiences and barriers encountered in the use of health services across the cancer continuum. The surveys were self-compiled web-based computer-aided web interview, conducted in Italy within the ‘OncoGender—Promoting Inclusion in Oncology’ project, led by the Italian national cancer society [Associazione Italiana di Oncologia Medica (AIOM)]-associated researchers. All members of AIOM were invited by e-mail to participate in the OHP survey. TGD persons were reached through advocacy groups and consumers’ panel. The recruitment was completed on a voluntary basis. Survey data were collected and managed using an online platform managed by ELMA Research, an independent pharmaceutical marketing agency. A total of 305 OHPs (13% of AIOM members) and 190 TGD individuals participated in the surveys. Only 19% of OHPs felt competent in providing care to TGD patients and 21% declared not to feel comfortable in treating TGD patients. Seventy-one percent of TGD persons reported that they had never joined any cancer screening program; 32% reported one or more acts of discrimination by health care providers. Seventy-two percent of OHPs recognized the lack of specific education on cancer care for TGD patients and deemed it necessary to receive adequate training. A general lack of knowledge among OHPs about TGD health issues seems to be the main driver of difficulties in providing assistance and of discriminatory attitudes against TGD individuals. Ultimately, this whole issue generates access barriers and contributes to lack of trust in health care services. Educational interventions and an implementation of person-centric cancer policies are urgently needed. •There is a knowledge gap among OHPs about TGD health issues.•32% of TGD persons reported one or more episodes of discrimination by health care providers.•Adherence to cancer screening programs among TGD persons in Italy is low.•Educational interventions for health care providers are claimed as useful by both providers and target population.
ISSN:2059-7029
2059-7029
DOI:10.1016/j.esmoop.2023.101578